Harish Manwani - May 7, 2025 Form 4 Insider Report for GILEAD SCIENCES, INC. (GILD)

Role
Director
Signature
/s/ Edward S. Son by Power of Attorney for Harish Manwani
Stock symbol
GILD
Transactions as of
May 7, 2025
Transactions value $
-$29,274
Form type
4
Date filed
5/8/2025, 08:18 PM
Previous filing
Apr 16, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
MANWANI HARISH Director 333 LAKESIDE DRIVE, FOSTER CITY /s/ Edward S. Son by Power of Attorney for Harish Manwani 2025-05-08 0001527726

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GILD Common Stock Award $0 +1.52K +11.78% $0.00 14.4K May 7, 2025 Direct F1
transaction GILD Common Stock Tax liability -$29.3K -296 -2.06% $98.90 14.1K May 7, 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GILD Non-qualified Stock Option (Right to Buy) Award $0 +6.81K $0.00 6.81K May 7, 2025 Common Stock 6.81K $98.90 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents 1,516 restricted stock units ("RSUs") granted under the Gilead Sciences, Inc. 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. The RSUs vested immediately upon the grant date of May 7, 2025.
F2 100% of the shares subject to the stock option vested immediately upon the grant date of May 7, 2025.